These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34168096)

  • 1.
    Hu S; Hu Z; Qin J; Lin C; Jiang X
    Aging (Albany NY); 2021 Jun; 13(12):15770-15784. PubMed ID: 34168096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
    Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
    Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine treatment on SARS-CoV-2 receptor ACE2, TMPRSS2 and NRP1 expression in human primary pterygium and conjunctival cells.
    Yao Y; Ma D; Xu Y; Yuan XL; Liang JJ; Chen SL; Jhanji V; Ng TK
    Exp Eye Res; 2022 Jan; 214():108864. PubMed ID: 34826419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues.
    Subbarayan K; Ulagappan K; Wickenhauser C; Seliger B
    Curr Cancer Drug Targets; 2021 Jul; 21(5):428-442. PubMed ID: 33292131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TMPRSS2 is a tumor suppressor and its downregulation promotes antitumor immunity and immunotherapy response in lung adenocarcinoma.
    Liu Z; Lu Q; Zhang Z; Feng Q; Wang X
    Respir Res; 2024 Jun; 25(1):238. PubMed ID: 38862975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comprehensive Analysis of NRP1 in Malignancies Provide Therapeutic Implication for Treating Cancer Patients Infected with SARS-CoV-2.
    Chen S; Zhang L; Song Y; Xie K; Wang Y; Liang Y
    Biochem Genet; 2024 Aug; 62(4):2399-2417. PubMed ID: 37938510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased TMPRSS2 expression by SARS-CoV-2 predicts the poor prognosis of lung cancer patients through metabolic pathways and immune infiltration.
    Liu X; Liu B; Shang Y; Cao P; Hou J; Chen F; Zhang B; Fan Y; Tan K
    Aging (Albany NY); 2022 Jan; 14(1):73-108. PubMed ID: 35017320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in lung cancer.
    Ilikci Sagkan R; Akin-Bali DF
    J Med Virol; 2020 Nov; 92(11):2637-2647. PubMed ID: 32492203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection.
    Kong Q; Xiang Z; Wu Y; Gu Y; Guo J; Geng F
    Mol Cancer; 2020 Apr; 19(1):80. PubMed ID: 32345328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cathepsin B is a potential therapeutic target for coronavirus disease 2019 patients with lung adenocarcinoma.
    Ding X; Ye N; Qiu M; Guo H; Li J; Zhou X; Yang M; Xi J; Liang Y; Gong Y; Li J
    Chem Biol Interact; 2022 Feb; 353():109796. PubMed ID: 35007526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate adenocarcinoma and COVID-19: The possible impacts of TMPRSS2 expressions in susceptibility to SARS-CoV-2.
    Cheng J; Zhou J; Fu S; Fu J; Zhou B; Chen H; Fu J; Wei C
    J Cell Mol Med; 2021 Apr; 25(8):4157-4165. PubMed ID: 33609069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles.
    Uddin MN; Akter R; Li M; Abdelrahman Z
    Chem Biol Interact; 2021 Feb; 335():109370. PubMed ID: 33422520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-omics of the expression and clinical outcomes of TMPRSS2 in human various cancers: A potential therapeutic target for COVID-19.
    Liu L; Qin JF; Zuo MZ; Zhou Q
    J Cell Mol Med; 2022 Feb; 26(3):709-724. PubMed ID: 34951103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.
    Cantuti-Castelvetri L; Ojha R; Pedro LD; Djannatian M; Franz J; Kuivanen S; van der Meer F; Kallio K; Kaya T; Anastasina M; Smura T; Levanov L; Szirovicza L; Tobi A; Kallio-Kokko H; Österlund P; Joensuu M; Meunier FA; Butcher SJ; Winkler MS; Mollenhauer B; Helenius A; Gokce O; Teesalu T; Hepojoki J; Vapalahti O; Stadelmann C; Balistreri G; Simons M
    Science; 2020 Nov; 370(6518):856-860. PubMed ID: 33082293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous expression of ACE2, TMPRSS2, and FURIN at single-cell resolution in advanced non-small cell lung cancer.
    Liu Z; Gu X; Li Z; Shan S; Wu F; Ren T
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3563-3573. PubMed ID: 35960376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of
    Fu J; Liu S; Tan Q; Liu Z; Qian J; Li T; Du J; Song B; Li D; Zhang L; He J; Guo K; Zhou B; Chen H; Fu S; Liu X; Cheng J; He T; Fu J
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting TMPRSS2 in SARS-CoV-2 Infection.
    Baughn LB; Sharma N; Elhaik E; Sekulic A; Bryce AH; Fonseca R
    Mayo Clin Proc; 2020 Sep; 95(9):1989-1999. PubMed ID: 32861340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
    Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
    EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression analysis identifies genes associated with SARS-COV-2 receptors, ACE2 and TMPRSS2, in normal human lung tissues.
    Hu RW; Liu C; Gong JP; Cao ZX
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2409-2414. PubMed ID: 33755980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential applications of prognostic and immunological marker transmembrane serine proteinase 2 in prediction, prevention and personalized treatment of lung cancer.
    Mu B; Zhang R; Pu Y; Yao J; Hu X; Zhao C
    Eur J Cancer Prev; 2023 Jan; 32(1):65-68. PubMed ID: 35170548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.